Island Pharmaceuticals Ltd Financial Flexibility Index
Island Pharmaceuticals Ltd financial flexibility index. Island Pharmaceuticals Ltd (ILA) has a Financial Flexibility Index of -5.03x as of June 2025. Free cash flow of AU$-1.69 Million (operating CF AU$-1.69 Million minus capex AU$5.00) represents -5% of total liabilities (AU$336.43K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Island Pharmaceuticals Ltd (2019–2024)
Financial flexibility index of Island Pharmaceuticals Ltd from 2019 to 2024. Historical Financial Flexibility Index trend for Island Pharmaceuticals Ltd across 6 annual periods. Explore Island Pharmaceuticals Ltd (ILA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Island Pharmaceuticals Ltd Financial Flexibility Index by Year (2019–2024)
Island Pharmaceuticals Ltd financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Island Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Island Pharmaceuticals Ltd (ILA) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -8.23x | AU$-2.77 Million | AU$-2.77 Million | AU$336.43K | ▼ -171.9% |
| 2023 | -3.03x | AU$-3.16 Million | AU$-3.16 Million | AU$1.05 Million | ▲ +70.5% |
| 2022 | -10.27x | AU$-2.71 Million | AU$-2.71 Million | AU$263.85K | ▼ -217.5% |
| 2021 | -3.23x | AU$-1.88 Million | AU$-1.88 Million | AU$580.73K | ▲ +18.4% |
| 2020 | -3.96x | AU$-938.23K | AU$-938.24K | AU$236.83K | ▼ -16588.4% |
| 2019 | -0.02x | AU$-16.00 | AU$-16.00 | AU$674.00 | — |